Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARS: Sympathetic Neurovascular Transduction and Sex Differences
NCT05997732Phase 4Recruiting
- Sponsor
- University of Alberta
- Start
- Oct 2023
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of phenylephrine, isoprenaline, norepinephrine, propranolol, phentolamine, sponsored by University of Alberta. Started Oct 2023; status: recruiting.
02
Drugs
phenylephrineisoprenalinenorepinephrinepropranololphentolamine
Beyond the preview
Go deeper on NCT05997732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997732.